- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/55 - AcidsEsters
Patent holdings for IPC class C07D 213/55
Total number of patents in this class: 299
10-year publication summary
21
|
26
|
20
|
19
|
18
|
23
|
19
|
28
|
19
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Sutro Biopharma, Inc. | 171 |
8 |
H. Lundbeck A/S | 1247 |
8 |
The Scripps Research Institute | 1346 |
7 |
Chugai Seiyaku Kabushiki Kaisha | 1355 |
6 |
Saudi Arabian Oil Company | 13155 |
6 |
Bristol-myers Squibb Company | 4898 |
5 |
Syngenta Crop Protection AG | 6054 |
5 |
Sumitomo Chemical Company, Limited | 9046 |
5 |
F. Hoffmann-La Roche AG | 7925 |
4 |
Gilead Sciences, Inc. | 2036 |
4 |
The Wistar Institute of Anatomy and Biology | 450 |
4 |
Merck Sharp & Dohme LLC | 3748 |
4 |
Janssen Pharmaceutica N.V. | 3392 |
3 |
Allergan, Inc. | 2349 |
3 |
FUJIFILM Corporation | 29367 |
3 |
The Board of Trustees of the University of Illinois | 2688 |
3 |
Abide Therapeutics, Inc. | 26 |
3 |
AC Immune S.A. | 262 |
3 |
Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 289 |
3 |
Chiesi Farmaceutici S.p.A. | 969 |
3 |
Other owners | 209 |